Felicia Heimer

Head of Rare Disease Compliance at Amgen and Co-Author of OIG's Practical Guidance for Health Care Governing Boards on Compliance Oversight

Speaker

Agenda Sessions

• From Compliance Leader to Board Member: Elevating Your Strategic Impact

  27 Apr, 2:15pm

  View Session

• OIG's Compliance Crosshairs: What Pharma Must Prioritize Now

  28 Apr, 10:10am

  View Session

At this event